Verrica Pharmaceuticals Stock (NASDAQ: VRCA) stock price, news, charts, stock research, profile.
Open | $2.75 |
Close | $2.82 |
Volume / Avg. | 888.88K / 429.58K |
Day Range | $2.75 - $2.97 |
52 Wk Range | 2.63 - 11.41 |
Market Cap | $120.38M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 21 |
Short Interest | 19.4% |
Days to Cover | 14.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Verrica Pharmaceuticals (NASDAQ:VRCA) through any online brokerage.
Other companies in Verrica Pharmaceuticals’s space includes: Universe Pharmaceuticals (NASDAQ:UPC), Rani Therapeutics Hldgs (NASDAQ:RANI), Telomir Pharmaceuticals (NASDAQ:TELO), Trevi Therapeutics (NASDAQ:TRVI) and Milestone Pharmaceuticals (NASDAQ:MIST).
Verrica Pharmaceuticals has a consensus price target of $11.57.
The stock price for Verrica Pharmaceuticals (NASDAQ: VRCA) is $2.8212 last updated August 23, 2024 at 5:29 PM EDT.
There are no upcoming dividends for Verrica Pharmaceuticals.
Verrica Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Verrica Pharmaceuticals.
Verrica Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.